CardioCommand, Inc.
... technology could make a real clinical contribution in the noninvasive monitoring of arterial blood pressure. Today, technology must also enable more efficient healthcare delivery.” ...
... technology could make a real clinical contribution in the noninvasive monitoring of arterial blood pressure. Today, technology must also enable more efficient healthcare delivery.” ...
If only cardiologists did properly measure blood pressure
... single physician completely followed all the techniques of BP measuring that were recommended by the American Heart Association (2). Yet, numerous studies have documented that BP measured carefully under standardized conditions in the physician’s office (3) is one of the most powerful and reliable p ...
... single physician completely followed all the techniques of BP measuring that were recommended by the American Heart Association (2). Yet, numerous studies have documented that BP measured carefully under standardized conditions in the physician’s office (3) is one of the most powerful and reliable p ...
PowerPoint プレゼンテーション - 埼玉医科大学総合医療センター 内分泌
... Figure 1- Kaplan-Meier curve of the occurrence of the pre-specified composite cardiovascular endpoint among patients randomized to bromocriptine-QR (solid line) or placebo (dashed line). The composite cardiovascular endpoint consisted of the time to first myocardial infarction, stroke, coronary r ...
... Figure 1- Kaplan-Meier curve of the occurrence of the pre-specified composite cardiovascular endpoint among patients randomized to bromocriptine-QR (solid line) or placebo (dashed line). The composite cardiovascular endpoint consisted of the time to first myocardial infarction, stroke, coronary r ...
Treatments - Heart Rhythm Society
... stopping life-threatening arrhythmias and are the most successful therapy to treat ventricular fibrillation, the major cause of sudden cardiac death. ICDs continuously ...
... stopping life-threatening arrhythmias and are the most successful therapy to treat ventricular fibrillation, the major cause of sudden cardiac death. ICDs continuously ...
Coronary Heart Disease Coronary heart disease, or CHD, is
... After damage has been done to the inner wall of an artery, fatty deposits known as plaque begin to build up. This process is known as atherosclerosis, and the plaque itself may be formed by cholesterol or other cellular residue within the bloodstream. Once these plaques have formed, if one should be ...
... After damage has been done to the inner wall of an artery, fatty deposits known as plaque begin to build up. This process is known as atherosclerosis, and the plaque itself may be formed by cholesterol or other cellular residue within the bloodstream. Once these plaques have formed, if one should be ...
Diastolic Dysfunction - Annals of Internal Medicine
... • Heart failure is when the heart is unable to pump blood effectively. • In some patients, this results from processes that make it harder for the heart to relax or fill between beats (diastolic dysfunction). • Unlike in other patients with heart failure, a measurement of how well the heart beats, t ...
... • Heart failure is when the heart is unable to pump blood effectively. • In some patients, this results from processes that make it harder for the heart to relax or fill between beats (diastolic dysfunction). • Unlike in other patients with heart failure, a measurement of how well the heart beats, t ...
Young Investigator Award
... Methods: Quasi experimental study enrolling 24 controlled hypertension and 24 normotensive subjects, collected by purposive sampling. Subjects received + 10.6 gr caffeinated coffee in 150 ml water with crossover protocol. Assessment of arterial stiffness using ultrasound 2D image of common carotid a ...
... Methods: Quasi experimental study enrolling 24 controlled hypertension and 24 normotensive subjects, collected by purposive sampling. Subjects received + 10.6 gr caffeinated coffee in 150 ml water with crossover protocol. Assessment of arterial stiffness using ultrasound 2D image of common carotid a ...
Managing Chronic Heart Failure
... Class IV: Patient unable to perform physical activity without discomfort, may have symptoms at rest. This patient will be considered for mechanical or pharmaceutical support, heart transplant or end-of-life care. ...
... Class IV: Patient unable to perform physical activity without discomfort, may have symptoms at rest. This patient will be considered for mechanical or pharmaceutical support, heart transplant or end-of-life care. ...
BNP - yeditepetip4
... the most commonly utilized cardiac enzyme test Dimer composed of 2 monomers: ...
... the most commonly utilized cardiac enzyme test Dimer composed of 2 monomers: ...
Unstable Angina - Cardiology Update FK UNAND
... The most common side effect of nitrates is headache due to venodilation, patients whom intermittently used nitrate preparation should be asked about headaches after nitrate use; lack of headache often indicates degradation of agent with a loss of therapeutic effect. Postural hypotension & syncope pa ...
... The most common side effect of nitrates is headache due to venodilation, patients whom intermittently used nitrate preparation should be asked about headaches after nitrate use; lack of headache often indicates degradation of agent with a loss of therapeutic effect. Postural hypotension & syncope pa ...
SEMC_Treatment of Atrial Fibrillation_FEB2016
... rhythm control. Rate control uses medication to slow down heart rate and control how many times a minute the heart’s ventricles contract. This is important because it allows the ventricles enough time to completely fill with blood. In this approach, abnormal heart rhythm will continue, however patie ...
... rhythm control. Rate control uses medication to slow down heart rate and control how many times a minute the heart’s ventricles contract. This is important because it allows the ventricles enough time to completely fill with blood. In this approach, abnormal heart rhythm will continue, however patie ...
The NewYork-Presbyterian/Columbia Valve Center
... • A trial to evaluate the safety and effectiveness of the Duraheart® Left Ventricular Assist System for bridgeto-transplant • The BIPACS trial is testing the benefits of temporary biventricular pacing for left ventricular dysfunction over the first day after cardiac surgery. Similar studies are bein ...
... • A trial to evaluate the safety and effectiveness of the Duraheart® Left Ventricular Assist System for bridgeto-transplant • The BIPACS trial is testing the benefits of temporary biventricular pacing for left ventricular dysfunction over the first day after cardiac surgery. Similar studies are bein ...
Association with acute ischemia and predictors of new
... ventricular ischemia with consequent neuro-humoral abnormalities and hemodynamic changes. The aims of this study were to evaluate the relationship between acute ischemia and NOAF and to identify predictors of NOAF in ST-segment elevation myocardial infarction (STEMI) patients (pts). Methods We retro ...
... ventricular ischemia with consequent neuro-humoral abnormalities and hemodynamic changes. The aims of this study were to evaluate the relationship between acute ischemia and NOAF and to identify predictors of NOAF in ST-segment elevation myocardial infarction (STEMI) patients (pts). Methods We retro ...
Overview of Coronary Artery Disease
... quality of the sensation is more vague and described as a mild pressure-like discomfort, an uncomfortable numb sensation, or a burning sensation. The site of the discomfort is usually retrosternal, but radiation is common and usually occurs down the ulnar surface of the left arm; the right arm and t ...
... quality of the sensation is more vague and described as a mild pressure-like discomfort, an uncomfortable numb sensation, or a burning sensation. The site of the discomfort is usually retrosternal, but radiation is common and usually occurs down the ulnar surface of the left arm; the right arm and t ...
Heart failure
... -Conditions that overwork the heart: including high blood pressure, valve disease, thyroid disease, kidney disease, diabetes, or congenital heart disease. heart has to work harder than it should to circulate blood throughout your body. Over time, the heart muscle may become thicker to compensate for ...
... -Conditions that overwork the heart: including high blood pressure, valve disease, thyroid disease, kidney disease, diabetes, or congenital heart disease. heart has to work harder than it should to circulate blood throughout your body. Over time, the heart muscle may become thicker to compensate for ...
beta blockers in ischemic heart disease as “cardioprotection”
... cardioprotective agents in stable and unstable angina are inferred and based in large part on the results of post-MI studies. Finally, in high-risk surgical patients, beta blockers seem to be cardioprotective when given pre-operatively although the length of time pre-operatively and post-operatively ...
... cardioprotective agents in stable and unstable angina are inferred and based in large part on the results of post-MI studies. Finally, in high-risk surgical patients, beta blockers seem to be cardioprotective when given pre-operatively although the length of time pre-operatively and post-operatively ...
STEMI Primer 2016
... *Patients with cardiogenic shock or severe heart failure initially seen at a non–PCI-capable hospital should be transferred for cardiac catheterization and revascularization as soon as possible, irrespective of time delay from MI onsetClass I, LOE: B). †Angiography and revascularization should not b ...
... *Patients with cardiogenic shock or severe heart failure initially seen at a non–PCI-capable hospital should be transferred for cardiac catheterization and revascularization as soon as possible, irrespective of time delay from MI onsetClass I, LOE: B). †Angiography and revascularization should not b ...
The Clinical Evidence: An Overview of ICD Studies in Primary
... prevention patients, those people who have not had a SCA or sustained VT. Three major clinical trials investigating ICD therapy in primary prevention patients (MADIT, MUSTT and MADIT II) have shown significant reductions in overall mortality (31-55%) over antiarrhythmics or conventional medical ther ...
... prevention patients, those people who have not had a SCA or sustained VT. Three major clinical trials investigating ICD therapy in primary prevention patients (MADIT, MUSTT and MADIT II) have shown significant reductions in overall mortality (31-55%) over antiarrhythmics or conventional medical ther ...
Exploring new concepts in the management of heart failure with
... recent paradigm has implicated the coronary endothelium as a primary mechanism driving the development of HFpEF (9). Dr. Li Zuo and his colleagues (12) review the research surrounding this concept and examine the integrative influence of reactive oxygen species and nitric oxide acting through the co ...
... recent paradigm has implicated the coronary endothelium as a primary mechanism driving the development of HFpEF (9). Dr. Li Zuo and his colleagues (12) review the research surrounding this concept and examine the integrative influence of reactive oxygen species and nitric oxide acting through the co ...
office ecg interpretation
... • The prognosis in patients with RBBB is related largely to the type and severity of any concurrent underlying heart disease and to the possible presence of other conduction disturbances. Long-term outcomes are generally excellent in patients without apparent heart disease, while those with RBBB in ...
... • The prognosis in patients with RBBB is related largely to the type and severity of any concurrent underlying heart disease and to the possible presence of other conduction disturbances. Long-term outcomes are generally excellent in patients without apparent heart disease, while those with RBBB in ...
Relation of Isovolumic Relaxation time to Left
... was started after 30 min of ischaemia first retrogradely with a pressure of 85 cm water and coronary flow of 14·9 ± 3·2 ml/min. All hearts fibrillated on reperfusion but resumed rhythmic contraction after 0·1-31·0 min. The CK concentration in the effluent began to increase dramatically only when spo ...
... was started after 30 min of ischaemia first retrogradely with a pressure of 85 cm water and coronary flow of 14·9 ± 3·2 ml/min. All hearts fibrillated on reperfusion but resumed rhythmic contraction after 0·1-31·0 min. The CK concentration in the effluent began to increase dramatically only when spo ...
View Abstract
... Stevens, Patrick L, MD, Lenihan, Daniel J, MD Background: An effective strategy for monitoring cardiac safety during anthracycline chemotherapy is not established. Serial left ventricular ejection fraction (LVEF) utilizing imaging is the current standard of care; however biomarkers may allow for ear ...
... Stevens, Patrick L, MD, Lenihan, Daniel J, MD Background: An effective strategy for monitoring cardiac safety during anthracycline chemotherapy is not established. Serial left ventricular ejection fraction (LVEF) utilizing imaging is the current standard of care; however biomarkers may allow for ear ...
Heart failure
... In case of A/V block or severe bradycardia → atropine followed by temporary PM if needed In life threatening arrhythmia → digoxinspecific fab antibodies Lidocaine and phenytoin could be used – try to avoid D/C cardioversion in non life threatening arrhythmia ...
... In case of A/V block or severe bradycardia → atropine followed by temporary PM if needed In life threatening arrhythmia → digoxinspecific fab antibodies Lidocaine and phenytoin could be used – try to avoid D/C cardioversion in non life threatening arrhythmia ...
Device Therapy for Stage C HFrEF
... • Ivabradine (“Corlanor”) is a new class of drug that selectively inhibits the If current in the sinoatrial node, reducing the heart rate • In a RCT of pts with HFrEF Ivabradine reduced HF hospitalizations but not mortality. • Class II indication: “can be beneficial to reduce HF hospitalization for ...
... • Ivabradine (“Corlanor”) is a new class of drug that selectively inhibits the If current in the sinoatrial node, reducing the heart rate • In a RCT of pts with HFrEF Ivabradine reduced HF hospitalizations but not mortality. • Class II indication: “can be beneficial to reduce HF hospitalization for ...